Strides Completes Acquisition Of Endo US Facility And ANDAs
The $24m Deal Involves Manufacturing Site And Multiple ANDAs From Endo
Two months after announcing the deal, Strides Pharma Science has closed its acquisition of a US manufacturing site and basket of ANDAs from Endo, doubling the company’s burgeoning US business and providing much-needed cash to the US-based company.
